Leigh Ellis

17PUBLICATIONS
151CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

Beatriz German, Katherine L Morel, Teia Noel

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|Feb 14, 2024
MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer.

Beatriz German, Jagpreet N Singh, Marcos AdS Fonseca

|Nov 14, 2023
Genetic and biological drivers of prostate cancer disparities in Black men.

Jun Gong, Daniel M Kim, Michael R Freeman

Pageof 3